The verdict is out! The ball is now in the...Read More
Transitioning to Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746...Read More
Did you know merely stating “How your benefits outweigh the...Read More
Post market Clinical follow-up (PMCF) is a proactive method for collection and evaluation of clinical data, confirm the safety of device and ensure continued acceptability of the risk identified and identify new risks that may arise for the medical devices which are already in market and are CE certified. PMCF is one of the segments of Post Market Surveillance and it is a continuous process that updates the quality management system with focus to areas like clinical evaluation, and risk management.
As per EU MDR 2017/745, the manufacturer shall consider the need to perform PMCF for every medical device and where PMCF is not required due to presence of sufficient clinical data a rational or detailed justification is to be documented within the technical documentation. As per the EU MDR, detailed and elaborated analysis of all the clinical data available needs to be performed in order to decide if PMCF is justified or not. If gaps are observed in the clinical data, PMCF studies are required.
Maven team provides complete end to end solution for your PMCF studies. Determining the need for performing PMCF studies as per EU MDR, if the PMCF studies are not applicable a detailed justification will be provided. Also, the data which is accepted under MDD may no longer be sufficient and adequate under the EU MDR. Consultants at Maven Profcon Services LLP, can help you with the following: